Familial Mediterranean Fever Treatment Doctors in Jordan

Familial Mediterranean fever is an inherited disorder of inflammatory regulation that causes recurrent attacks of short-lived fever with severe abdominal pain resembling appendicitis, or pleuritic chest pain that makes breathing difficult, or pain and swelling in a single large joint, usually with raised inflammatory markers in the blood. An attack typically resolves on its own within one to three days, after which the person returns to normal. It is more common in populations of the Mediterranean basin and the Arab region, so in Jordan it is considered early whenever attacks of fever and abdominal pain recur without an obvious cause. The diagnosis is primarily clinical: the pattern, brevity and recurrence of attacks, the family history, inflammatory markers during an attack, and the response to preventive treatment. Genetic testing supports the diagnosis rather than deciding it, and one point must be stated frankly: **a positive genetic result on its own is not a diagnosis**, because carrying a variant in the responsible gene is common among healthy people in our region and its presence does not necessarily mean disease. Conversely, a negative or inconclusive test does not exclude the disease when the clinical picture is characteristic and the response to treatment is good. The decision rests on clinical assessment and the course of the illness, not on a laboratory report. Why is early diagnosis urgent? Because the most dangerous feature is not the painful attack but the ongoing inflammation between attacks, which over years can lead to amyloid deposition in the kidneys, protein loss in the urine and eventually kidney failure. In addition, **early diagnosis and regular treatment prevent permanent joint damage** in patients whose arthritis recurs or becomes chronic. For this reason urine protein and inflammatory markers are monitored periodically even during quiet periods. Treatment rests on daily continuous colchicine, which is not merely a painkiller for an attack but a preventive medicine taken every day, long term; its regular use is what reduces attacks and protects the kidneys from amyloidosis. Stopping it once the patient feels well, or between attacks, is the commonest reason attacks return and kidney complications develop. In patients whose attacks continue or whose inflammatory markers stay high despite good adherence, biological medicines that target the inflammatory pathway are available and are decided by a specialist; they are neither started nor stopped by the patient. The limits are clear. Colchicine does not correct the gene and does not cure the disease permanently, and it may not prevent every attack in every patient, but its greatest value lies in preventing the serious complication. Diets and herbal remedies do not treat the disease and do not replace medication. Removing the appendix does not end recurrent abdominal pain, and many patients undergo that operation before the diagnosis is made. Most importantly, **do not assume every abdominal pain is an attack**: an attack usually settles within three days, and if pain persists or changes in character it may be a genuine surgical emergency.